General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Xue S et al. – Potassium iodide is an anti–fungal drug listed in the World Health Organization (WHO) essential drug list and generally thought to be the first choice for cutaneous sporotrichosis including fixed and lymphocutaneous types, in developing countries. No randomised controlled trials (RCTs) of oral potassium iodide versus placebo were found and thus its efficacy and safety could not be analysed in this review. There is a need for randomised placebo controlled trials of oral potassium iodide in this area.

Related Articles

Multiple Subcutaneous Mycetomas caused by Pseudallescheria boydii: Response to therapy with oral potassium iodide solution
Journal of Infection, 10/12/09    Relevance Score: 66%

Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source: report of a first case in southern Karnataka, India
International Journal of Dermatology, 10/30/09    Relevance Score: 43%

Terbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis
Journal of the European Academy of Dermatology and Venereology, 10/26/09    Relevance Score: 43%

Effect of Potassium Citrate Therapy on the Risk of Renal Stone Formation During Spaceflight
The Journal of Urology, 10/22/09    Relevance Score: 43%

Iodide protects hyaluronate from oxidative stress
Spektrum der Augenheilkunde, 10/01/09    Relevance Score: 43%

Today in Derm Infectious Disease...keeping you current

Cutaneous leishmaniasis treated with itraconazole
Dermatologic Therapy, 11/20/09

Identification of B-Cell Epitopes on Virus-Like Particles of Cutaneous Alpha-Human Papillomaviruses
Journal of Virology, 11/20/09

The Antituberculosis Drug Pyrazinamide Affects the Course of Cutaneous Leishmaniasis In Vivo and Increases Activation of Macrophages and Dendritic Cells
Antimicrobial Agents and Chemotherapy, 11/20/09

Today in Fungal Infections...keeping you current

Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species
Antimicrobial Agents and Chemotherapy, 11/20/09

Paradoxical Growth of Candida dubliniensis Does Not Preclude In Vivo Response to Echinocandin Therapy
Antimicrobial Agents and Chemotherapy, 11/20/09

Neosartorya udagawae, an emerging agent of aspergillosis: How different is it from Aspergillus fumigatus
Journal of Clinical Microbiology, 11/20/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address